The CMCO strives to promote a culture of diversity and inclusivity for all its members, focusing on career development and innovative approaches to science.
Center of Molecular and Cellular Oncology
The Center of Molecular and Cellular Oncology (CMCO) fosters and mentors physician-scientists as they advance their laboratory-based research programs to bridge fundamental cancer biology with clinical investigation for the translation of basic discoveries into better therapeutics, treatments or diagnosis. Physician-scientist faculty in the CMCO hold primary appointments in medical oncology or hematology at Yale Cancer Center (YCC), and participate in all divisional activities, interacting with other members of YCC. In addition, the CMCO members are part of one or more YCC Clinical Research Teams (CRTs) and YCC Research Programs relevant to their laboratory research and clinical interests, promoting a collaborative environment for the better understanding of cancer biology. The CMCO strives to promote a culture of diversity and inclusivity for all its members, focusing on career development and innovative approaches to science.
Contact Us
Markus Müschen, MD-PhD
Arthur H. and Isabel Bunker Professor of Hematology
Director, Center of Molecular and Cellular Oncology
Office Phone: 203-737-2792
Anand Vasudevan, PhD
Program Manager
Office Phone: 203-737-1268
Center of Molecular and Cellular Oncology
Yale Cancer Center
300 George Street, Suite 6400
New Haven, CT 06511
Yale Cancer Center Grand Rounds | January 5, 2021Markus Muschen, MD, PhD
Yale Cancer Center Grand Rounds | November 10, 2020Robbert Bona, MD and Jeffrey Ishizuka, MD, DPhil
Faculty
Arthur H. and Isabel Bunker Professor of Medicine (Hematology) and Professor of Immunobiology; Director, Center of Molecular and Cellular Oncology; Chief, Division of Basic Science, Yale Cancer Center
EducationPhD, Institute for Genetics Cologne, 2003; MD, Heinrich-Heine-Universität Düsseldorf, 1999Assistant Professor
EducationMD, Harvard Medical School, 2013; DPhil, Oxford University, 2008; BA, Williams College, 2004Assistant Professor
EducationMD, Harvard Medical School, 2007; PhD, Yale University, 2002Assistant Professor of Medicine (Medical Oncology), Louis Goodman and Alfred Gilman Yale Scholar
EducationMD, Icahn School of Medicine at Mount Sinai, 2013; PhD, Courant Institute of Mathematical Sciences at New York University, 2012; AB, Princeton University, 2006Assistant Professor of Medicine (Hematology)
EducationPhD, University Paris Diderot, 2013; MS, University Pierre and Marie Curie, 2009; MS, Stockholm University, 2008; BS, University of Burgundy, 2007
- November 14, 2024
Dr. Shalin Kothari NBC CT Interview: What You Should Know About Non-Hodgkins Lymphoma, TV Actor Dave Coulier's cancer diagnosis
- November 05, 2024
Clinical Trial to Help Patients Undergoing Cancer Immunotherapy
- September 20, 2024
Are Comprehensive Genetic Profiles Helping Patients with Cancer?
- September 19, 2024
Gift to Advance Cancer Treatment by Targeting Toxic Side Effects
- September 11, 2024Source: OncLive
Dr Braun on the Role of Biomarkers in Guiding Adjuvant Treatment for RCC
- August 30, 2024
Yale Research Highlights Unmet Needs for Patients With Melanoma Who Progress or Relapse After Immunotherapy Treatment